BOUNDLESS BIO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
BOUNDLESS BIO, INC. (BOLD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 236.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-07
- BOUNDLESS BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 104.00K shares, a 69.14% decline year-over-year.
- BOUNDLESS BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 132.00K shares, a 61.40% decline year-over-year.
- BOUNDLESS BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 135.00K shares, a 68.44% decline year-over-year.
- BOUNDLESS BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 283.00K shares, a 91.98% decline year-over-year.
- BOUNDLESS BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 1.10M shares, a 72.30% decline from fiscal 2024.
- BOUNDLESS BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 3.96M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 104.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 236.00K shares 10-Q · filed 2026-08-07 | 371.00K shares derived: sum of 3 quarters · filed 2026-08-07 | 654.00K shares derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 132.00K shares 10-Q · filed 2026-05-08 | 267.00K shares derived: sum of 2 quarters · filed 2026-05-08 | 550.00K shares derived: sum of 3 quarters · filed 2026-05-08 | 887.00K shares derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-12-31 | 135.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 418.00K shares derived: sum of 2 quarters · filed 2026-03-09 | 755.00K shares derived: sum of 3 quarters · filed 2026-03-09 | 1.10M shares 10-K · filed 2026-03-09 |
| 2025-09-30 | 283.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 620.00K shares derived: sum of 2 quarters · filed 2025-11-05 | 962.00K shares 10-Q · filed 2025-11-05 | 1.39M shares derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | 337.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | 679.00K shares 10-Q · filed 2025-08-05 | 1.11M shares derived: sum of 3 quarters · filed 2025-08-05 | 4.63M shares derived: sum of 4 quarters · filed 2025-08-05 |
| 2025-03-31 | 342.00K shares 10-Q · filed 2025-05-09 | 769.76K shares derived: sum of 2 quarters · filed 2025-05-09 | 4.30M shares derived: sum of 3 quarters · filed 2025-05-09 | 4.30M shares derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-12-31 | 427.76K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 3.96M shares derived: sum of 2 quarters · filed 2025-03-27 | 3.96M shares derived: sum of 3 quarters · filed 2025-03-27 | 3.96M shares 10-K · filed 2025-03-27 |
| 2024-09-30 | 3.53M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 3.53M shares derived: sum of 2 quarters · filed 2024-11-07 | 3.53M shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -6.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 4.03K shares 10-Q · filed 2024-08-12 | ||
| 2024-03-31 | 4.04K shares 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |